Overview


According to FutureWise analysis the market for multiplex assay in 2023 is US$ 3.82 billion, and is expected to reach US$ 7.61 billion by 2031 at a CAGR of 9.02%.

A multiplex assay is a type of laboratory test that allows for the simultaneous measurement of multiple analytes in a single sample. This technology enables researchers and healthcare providers to gather more information from a single sample, providing a more holistic overview of a patient's health status. Multiplex assays are widely used in the life sciences industry, with applications in research, drug discovery, and clinical diagnostics. They can be used to measure a wide range of analytes, including proteins, nucleic acids, and small molecules, and can be customized to measure specific biomarkers or disease markers.

Multiplex assays are typically based on one of several technologies, including bead-based assays, microarray technologies, and next-generation sequencing (NGS) platforms. In a bead-based assay, different analytes are conjugated into beads of different colours, allowing them to be distinguished from one another using flow cytometry. Microarray technologies use a solid surface, such as a glass slide, to immobilize different analytes in specific locations, enabling simultaneous measurement of multiple targets in a single sample. NGS platforms can be used for multiplex assays by sequencing multiple samples at the same time, allowing for the measurement of multiple analytes in parallel.

FutureWise Market Research has published a report that provides an insightful analysis of Multiplex Assay Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Multiplex Assay Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Abbott Laboratories
  • Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Bio-Rad Laboratories
  • Biomérieux
  • Bühlmann Laboratories
  • Sekisui Medical
  • Randox Laboratories

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Multiplex Assay Market:

In May 2022, PathoKey MP UTI ID and AMR PCR Test were introduced by Vela Diagnostics solely for research purposes. This multiplex PCR-based assay allows in vitro identification and differentiation of 14 pathogens responsible for urinary tract infections (UTI).

The multiplex assay market is a rapidly growing segment of the global life sciences industry, driven by a variety of market dynamics. These dynamics are shaped by a range of factors, including advances in technology, changing healthcare needs, and the increasing demand for personalized medicine. One of the key drivers of the multiplex assay market is the development of new and advanced technologies. The development of cutting-edge multiplex assay systems, including bead-based assays, microarray technologies, and next-generation sequencing (NGS) platforms, has significantly increased in recent years. These technologies enable the simultaneous measurement of multiple analytes in a single sample, allowing for more efficient and cost-effective testing. Another factor driving the growth of the multiplex assay market is the increasing demand for personalized medicine. As healthcare providers seek to deliver more individualized treatment plans, multiplex assays are becoming an essential tool for identifying patient-specific biomarkers and disease signatures. These assays enable healthcare providers to select the most appropriate treatment options for each patient, improving outcomes and reducing healthcare costs. Furthermore, the need for rapid and accurate diagnosis is also driving demand for multiplex assays. With the ongoing COVID-19 pandemic, multiplex assays have become a crucial tool for monitoring and diagnosing the disease, enabling healthcare providers to quickly identify and isolate infected individuals.

However, the market for multiplex assays also faces challenges, including the high cost of equipment and reagents, the need for specialized expertise to perform and interpret tests, and concerns around data quality and standardization.

By Product and Service

  • Consumables
  • Instruments
  • Software and Services

By Type 

  • Protein Multiplex Assays
    •   Planar Protein Assays
    •  Bead-Based Protein Assays
    •  Other Protein Assays
  • Nucleic Acid Multiplex Assays
    •   Planar Nucleic Acid Assays
    •   Bead-Based Nucleic Acid Assays
    •   Other Nucleic Acid Assays
  •  Cell-Based Multiplex Assays

By Technology 

  • Flow Cytometry
  • Fluorescence Detection
  • Luminescence
  • Multiplex Real-Time PCR
  • Other Technologies

By Application 

  • Research & Development
    •   Drug Discovery & Development
    •   Biomarker Discovery & Validation
  • Clinical Diagnostics
    •   Infectious Diseases
    •   Cancer
    •   Cardiovascular Diseases
    •   Autoimmune Diseases
    •   Nervous System Disorders
    •    Metabolism & Endocrinology Disorders
    •   Other Diseases

By End User

  • Pharmaceutical & Biotechnology Companies
  •  Hospitals & Research Institutes
  • Reference Laboratories
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The rising prevalence of chronic diseases like HIV, gastrointestinal disorders, CNS disorders, and others, the growing popularity of multiplex assays over single assays, rising product approvals, rising investments, and significant initiatives taken by the key market players are the main factors propelling the growth of the North American multiplex assays market. It is anticipated that the United States will see substantial growth within North America over the course of the study. The market for multiplex assays is predicted to grow due to the increased burden of chronic illnesses. For instance, the HIV Government factsheet from May 2021 estimates that there were about 1.2 million HIV-positive individuals in the United States. As a result, the demand for multiplex assays is anticipated to increase throughout the projected period due to the country's increasing frequency of infectious illnesses. Additionally, based on product & services; consumables segment and based on end-user; pharmaceutical & biotechnology companies segment hold the largest market share in 2022.

  • Tier 1 players- established companies in the market with major market share Tier 2 players New Entrants Emerging players which are growing rapidly
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly

  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global Multiplex Assays Market By Product and Service, By Type, By Technology, By Application, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers, and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Multiplex Assay Market Variables, Trends and Scope

    •         1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Multiplex Assay Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Multiplex Assay Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Multiplex Assay Market, By Product and Service Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Consumables
        2. Instruments
        3. Software and Services

  • 8.   Multiplex Assay Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Protein Multiplex Assays
         1.1. Planar Protein Assays
         1.2. Bead-Based Protein Assays
         1.3. Other Protein Assays
        2. Nucleic Acid Multiplex Assays
         2.1. Planar Nucleic Acid Assays
         2.2. Bead-Based Nucleic Acid Assays
         2.3. Other Nucleic Acid Assays
        3. Cell-Based Multiplex Assays

  • 9.   Multiplex Assay Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Flow Cytometry
        2. Fluorescence Detection
        3. Luminescence
        4. Multiplex Real-Time PCR
        5. Other Technologies

  • 10.   Multiplex Assay Market, By Applications Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Researchand Development
         1.1. Drug Discovery and Development
         1.2. Biomarker Discovery and Validation
        2. Clinical Diagnostics
         2.1. Infectious Diseases
         2.2. Cancer
         2.3. Cardiovascular Diseases
         2.4. Autoimmune Diseases
         2.5. Nervous System Disorders
         2.6. Metabolism and Endocrinology Disorders
         2.7. Other Diseases

  • 11.   Multiplex Assay Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Pharmaceutical and Biotechnology Companies
        2. Hospitals and Research Institutes
        3. Reference Laboratories
        4. Other End Users

  • 12.   North America Multiplex Assay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Multiplex Assay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Multiplex Assay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Multiplex Assay Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Hoffmann-La Roche
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Siemens Healthineers
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Thermo Fisher Scientific
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Danaher Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bio-Rad Laboratories
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Biomérieux
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Bühlmann Laboratories
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Sekisui Medical
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Randox Laboratories
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 20.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11